IFIH1 and interstitial lung disease: Using the Kaplan–Meier survival analysis, the MDA5+ DM-ILD individuals with anti-MDA5 IgG1 ≥ 1:100 and NLR ≥ 5.22 at baseline had significantly the lowest survival (wilcoxon test, P = 0.0409, Fig. 3B).